Unilabs Selects Proscia’s AI For Skin Pathology

Unilabs and Proscia have announced that the diagnostic group has chosen Proscia’s DermAI to advance its aspiration of becoming the most digitally-driven diagnostic group – enabling better decisions for a healthier tomorrow. The artificial intelligence-enabled technology will first be deployed in Sweden and then rolled out across other countries where Unilabs serves patients.

*DermAI is for research use only.